Feature | MCTD (n = 50) | Controls (n = 38) | Pvalue, MCTD vs. controlsa | MCTD/CVD+ (n = 23) | MCTD/CVD- (n = 27) | Pvalue, MCTD/CVD+ vs. MCTD/CVD-b |
---|---|---|---|---|---|---|
Anti-U1RNP (U/ml) | 20.18 ± 14.6 | 8.02 ± 3.5 | <0.001 | 30.3 ± 14.6 | 11.51 ± 7.28 | <0.001 |
Anti-CL IgG/IgM (U/ml) | 13.98 ± 12.2 | 6.06 ± 2.93 | <0.001 | 21.02 ± 15.04 | 7.98 ± 2.95 | <0.001 |
AECA (IU/ml) | 50.1 ± 34.5 | 17.1 ± 8.48 | <0.001 | 62.9 ± 26.3 | 39.1 ± 37.2 | <0.001 |
Thrombomodulin (ng/ml) | 12.2 ± 8.1 | 3.2 ± 1.3 | <0.001 | 15.9 ± 5.2 | 9.0 ± 8.8 | <0.001 |
vWFAg (%) | 224.1 ± 115 | 89.4 ± 27.1 | <0.001 | 311.5 ± 72.0 | 149.7 ± 90.0 | <0.001 |
FMD (%) | 4.76 ± 4.2 | 8.74 ± 5.05 | <0.001 | 3.54 ± 2.9 | 5.81 ± 4.87 | 0.0002 |
NMD (%) | 14.35 ± 6.67 | 17.16 ± 6.7 | 0.073 | 13.54 ± 6.06 | 15.03 ± 7.15 | 0.1283 |
IMT (mm) | 0.64 ± 0.13 | 0.53 ± 0.14 | <0.001 | 0.72 ± 0.11 | 0.57 ± 0.1 | <0.001 |